US 9290491
Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
granted A61KA61K31/46A61K31/485
Quick answer
US patent 9290491 (Crystalline forms of an 8-azabicyclo[3.2.1]octane compound) held by Theravance Biopharma R&D IP, LLC expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/46, A61K31/485, A61K45/06, A61P